Can a nanoparticle that mimics Salmonella effectively combat tumor chemotherapy resistance?
Department of Microbiology & Physiological Systems, University of Massachusetts Medical School, 368 Plantation Street, Worcester, MA 01655, USA.
Regino
R
Mercado-Lubo
Department of Microbiology & Physiological Systems, University of Massachusetts Medical School, 368 Plantation Street, Worcester, MA 01655, USA.
Beth A
BA
McCormick
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000378:metabolism; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D001426:Bacterial Proteins / Q000737:chemistry / Q000235:genetics / Q000627:therapeutic use; D004337:Drug Carriers / Q000737:chemistry; D016503:Drug Delivery Systems; D018432:Drug Resistance, Multiple; D019008:Drug Resistance, Neoplasm; D005818:Genetic Engineering / Q000379:methods; D006801:Humans; D050997:Nanomedicine / Q000379:methods; D053758:Nanoparticles / Q000737:chemistry / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000628:therapy*; D012475:Salmonella / Q000737:chemistry / Q000235:genetics*
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000970:Antineoplastic Agents; D001426:Bacterial Proteins; D004337:Drug Carriers
Salmonella; cancer; drug delivery; effector proteins; multidrug resistance; nanoparticles; therapeutic adjuvant